It is highly encouraging to see important outcomes from ESOT TLJ 2.0 highlighted in this article from The Lancet Medical Journal, exploring why people with HIV should join the organ donor register.
Paolo Grossi, leader of Workstream 2 – CMV infection and disease – at TLJ 2.0 had stated that given the advances in antiretroviral therapy (ART) and transplantation science, the time had come to explore giving HIV-infected organs to people on the waiting list without the virus.
You can read the article in full here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2821%2900084-2/fulltext?rss=yes
